Donald A. Denkhaus - 10 Jan 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Donald A. Denkhaus
Issuer symbol
CPRX
Transactions as of
10 Jan 2022
Net transactions value
+$101,200
Form type
4
Filing time
11 Jan 2022, 17:22:45 UTC
Previous filing
06 Jan 2022
Next filing
16 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $101,200 +40,000 +14% $2.53 317,666 10 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -40,000 -12% $0.000000 284,834 10 Jan 2022 Common Stock 40,000 $2.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vested in two equal tranches beginning on December 30, 2015.